1
At the same time, consistent differences between atypical antipsychotics have been demonstrated.
2
Lurasidone belongs to a new generation of schizophrenia drugs known as atypical antipsychotics.
3
Bifeprunox is part of a family of drugs called atypical antipsychotics.
4
No anticonvulsants or atypical antipsychotics appear in the top 20 of treatments delivered.
5
If these interventions are insufficient, then atypical antipsychotics should be considered.
6
Recent studies have shown an increase in the prescribing of atypical antipsychotics in children.
7
Recently, several double-blind studies of newer atypical antipsychotics have been conducted in therapy-resistant patients.
8
These observations may help in the understanding of the therapeutic action of atypical antipsychotics.
9
Other atypical antipsychotics are promising but more evidence is required.
10
With the widespread use of atypical antipsychotics, current long-term maintenance strategies may need a reappraisal.
11
This effect may be more pronounced for atypical antipsychotics.
12
This mechanism may be involved in the elevation of extracellular DA produced by atypical antipsychotics.
13
It is disrupted in schizophrenia patients and the disruption can be reversed with atypical antipsychotics.
14
Objectives: The development of long-acting, injectable atypical antipsychotics has provided a new paradigm for schizophrenia treatment.
15
Since the introduction of atypical antipsychotics success criteria of an effective antipsychotic treatment are more comprehensive.
16
The incidences for typical and atypical antipsychotics showed trends similar to those of the respective prevalences.
